Motion Preservation Device Market Size, Share, & Trends Analysis - Global - 2025-2031 - Includes: Artificial Disc and Dynamic Stabilization Devices
Description
Global Motion Preservation Device Market Report, 2025 Edition
Executive Summary
The global motion preservation device market was valued at over $1.1 billion in 2024. The market is expected to grow at a compound annual growth rate (CAGR) of 5.4 percent, reaching over $1.6 billion by 2032.
This report covers artificial disc and dynamic stabilization devices, which together form the complete global market for motion preservation systems. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and it analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report provides historical data to 2022 and forecasts through 2032.
The scope reflects how health systems and surgical centers evaluate spinal motion preservation as an alternative to fusion. Demand continues to expand as patients and physicians favor procedures that maintain natural motion, reduce adjacent segment disease, and lower the likelihood of revision surgeries.
Market Overview
Motion preservation devices, including artificial discs and dynamic stabilization systems, are designed to restore spinal function while preserving the spine’s normal biomechanics. These technologies serve as alternatives to fusion, which permanently restricts motion at the treated segment.
Growth is being driven by the combination of favorable clinical outcomes, rising patient awareness, and improved reimbursement structures. Artificial discs, used primarily in cervical and lumbar applications, mimic the natural movement of the disc while providing stability. Dynamic stabilization devices, applied in posterior approaches, limit excessive motion while maintaining controlled flexibility. Both device types are expanding adoption as more surgeons receive specialized training and as supporting long-term data becomes available.
Historically, fusion procedures dominated surgical treatment for spinal degeneration. However, evidence linking fusion to adjacent segment degeneration and limited range of motion has increased interest in motion-preserving techniques. Studies indicate that when patients are given a choice between a fusion and a motion-preserving procedure, they generally prefer motion preservation when cost is not a factor. This preference has accelerated procedural adoption, particularly in developed healthcare markets with established reimbursement pathways.
Regulatory and reimbursement landscapes are also improving. Several countries have revised coverage to include cervical and, in selected cases, lumbar artificial discs, acknowledging consistent clinical benefit and durability. As data from multi-center studies continues to demonstrate safety and efficacy, motion preservation is expected to capture a growing share of spine procedures traditionally treated with fusion.
Market Drivers
Alternative to Fusion
Artificial discs aim to maintain the spine’s natural range of motion, contrasting with spinal fusion, which restricts movement and may lead to additional stress on adjacent levels. Clinical studies show that patients treated with artificial discs experience faster recovery and reduced likelihood of secondary procedures. As awareness of these benefits increases, patients and physicians are shifting preference toward motion-preserving devices.
Additionally, evidence suggests that spinal fusion patients face higher rates of revision surgery due to adjacent segment degeneration. These outcomes reinforce clinical confidence in motion preservation, supporting growth in both cervical artificial discs (CADs) and lumbar artificial discs (LADs) over the forecast period.
Reimbursement Changes
Reimbursement has a strong influence on procedure volumes. For lumbar artificial discs, coverage expansion is expected as favorable results accumulate, with increasing acceptance among private insurers. Reimbursement rates have improved steadily over the past several years, allowing more patients to access motion-preserving technologies.
Cervical artificial discs have seen a particularly favorable shift. Positive clinical outcomes and long-term reliability have led to broader reimbursement acceptance, especially where CADs demonstrate equivalence or superiority to traditional cervical fusion. This trend continues to create a stable financial environment for hospitals and manufacturers operating in the segment.
Clinical Indications for CADs
Cervical artificial discs have fewer contraindications than their lumbar counterparts. Because the cervical spine bears less weight, it is less prone to instability issues that limit LAD adoption. Consequently, CADs can be implanted in a broader range of patients and at multiple levels, expanding the addressable market. Multi-level cervical procedures further increase unit sales potential. As physicians gain familiarity with implant techniques and clinical outcomes, CADs are expected to see consistent growth across all major regions.
Patient Preference and Education
Patient education initiatives emphasizing mobility preservation, quality of life, and lower revision rates have strengthened demand for motion preservation over fusion. As access to medical information grows and more patients request less invasive options, surgeon recommendations are increasingly aligned with patient expectations, reinforcing the adoption of these technologies.
Market Limiters
Clinical Contraindications for LADs
The most significant constraint on the lumbar artificial disc market is its limited clinical indication set. Contraindications include osteoporosis, spondylolisthesis, obesity, and instability of the vertebral column. LADs are currently indicated for single-level use only, reducing the eligible patient population.
Another limitation is procedural complexity. LAD implantation often requires a more invasive posterior approach, which is unfamiliar to some surgeons and presents additional challenges. Although newer LAD designs are being developed for anterior implantation to simplify access, widespread adoption will depend on further regulatory approvals and published outcomes.
Traditional Fusion Procedures
Conventional fixation and fusion continue to represent the standard of care for many indications. Fusion devices are less costly, have established reimbursement, and remain widely available. Surgeons comfortable with fusion techniques may be hesitant to switch to motion preservation until longer-term data supports clear superiority. Cost differences also influence hospital purchasing decisions, especially in regions where motion preservation devices are viewed as premium technologies.
Training and Infrastructure
Adoption of artificial discs and dynamic stabilization systems requires specialized training and equipment. Institutions without experienced teams or imaging capabilities may delay adoption. Additionally, some payers require documentation of surgeon training or device certification to qualify for reimbursement, limiting procedural accessibility in lower-volume centers.
Regulatory Variability
Regional variations in regulatory approval and reimbursement timelines can delay market penetration. Markets with more conservative evaluation frameworks or complex pre-market submission requirements tend to adopt new disc technologies more slowly, impacting overall global growth rates.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
Qualitative Coverage
Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, and disease overviews relevant to motion preservation.
Time Frame
Base year 2024, forecasts 2025 through 2032, historical data 2022 to 2024.
Data Sources
Primary interviews with spinal surgeons, device manufacturers, and healthcare administrators; regulatory filings; reimbursement databases; and iData Research’s internal MedTech dataset.
Method Note
Revenue models are based on units multiplied by ASP, cross-checked against procedure numbers and replacement cycles.
Care Settings
Hospitals, specialty spine centers, and select ambulatory surgery centers offering motion-preserving spinal procedures.
Markets Covered and Segmentation
Motion Preservation Device Market – Further Segmented Into:
Artificial Disc
Dynamic Stabilization
Each segment is analyzed by units, ASPs, and market values, with forecasts to 2032 and historical trends to 2022.
Competitive Analysis
ZimVie / Highridge Medical led the global motion preservation device market in 2024. The company maintained its leadership across most major regions, driven primarily by the success of its Mobi-C® Cervical Artificial Disc. The Mobi-C® system’s proven design, multi-level indication, and strong clinical evidence have supported broad adoption and reimbursement coverage. Following the company’s transition under Highridge Medical, product performance and brand recognition continue to strengthen its position globally.
Globus Medical / NuVasive was the second-largest competitor in 2024, supported by its SECURE®-C and SECURE®-C3 cervical disc systems, designed to replicate natural motion and enhance post-operative imaging quality. Globus also maintains share in the dynamic posterior stabilization and interspinous fixation segments. NuVasive contributes to this leadership through its Simplify® Cervical Disc, a motion-preserving, MRI-compatible solution that demonstrates strong clinical results. Following their merger, the combined company leverages a broad spine portfolio, integrating motion preservation with navigation and surgical planning systems.
Orthofix ranked third globally in 2024. Its M6-C™ Artificial Cervical Disc, acquired through the Spinal Kinetics merger, anchors its presence in cervical motion preservation. Orthofix also participates in dynamic stabilization technologies designed to maintain flexibility in non-fusion procedures. The company maintains a strong footprint in North America and Europe, supported by training partnerships and product innovation in motion restoration.
Collectively, these three manufacturers represent the majority of global motion preservation revenue. Competition is expected to intensify as additional disc technologies gain regulatory approval and as new entrants introduce next-generation dynamic systems with improved biomechanical performance.
Technology and Practice Trends
Cervical artificial discs continue to expand due to favorable indications, multi-level capabilities, and strong long-term outcomes.
Lumbar artificial discs face slower growth but benefit from active research into improved materials and anterior surgical approaches.
Dynamic stabilization systems offer hybrid solutions that maintain partial motion and can be used adjunctively with fusion in selective cases.
Material innovation includes titanium endplates, viscoelastic cores, and advanced polymer composites designed to mimic natural disc properties.
MRI compatibility and imaging clarity improvements support better post-operative monitoring.
Minimally invasive techniques for disc implantation are gaining popularity, reducing recovery times and hospital stays.
Integration with navigation and robotic guidance enhances accuracy and reproducibility during device placement.
Post-market studies continue to evaluate device durability and long-term biomechanics, helping strengthen regulatory and payer confidence.
Geography
This edition provides global coverage for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Why This Report
Where are the largest and fastest-growing opportunities within the motion preservation market by device type and region
How will patient preference for mobility and reimbursement changes influence market expansion
What are the clinical and procedural barriers affecting LAD versus CAD adoption
How do training, infrastructure, and regulatory factors shape adoption curves across geographies
What are the key technology trends, including dynamic stabilization and anterior approach LADs
How are leading players—ZimVie, Globus Medical/NuVasive, and Orthofix—positioning their portfolios and partnerships for continued growth
The Global Motion Preservation Device Market Report from iData Research answers these questions with procedure-based models, company share data, and price analysis. Use it to quantify opportunity, align strategic planning, and guide investment or product development decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global motion preservation device market was valued at over $1.1 billion in 2024. The market is expected to grow at a compound annual growth rate (CAGR) of 5.4 percent, reaching over $1.6 billion by 2032.
This report covers artificial disc and dynamic stabilization devices, which together form the complete global market for motion preservation systems. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and it analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report provides historical data to 2022 and forecasts through 2032.
The scope reflects how health systems and surgical centers evaluate spinal motion preservation as an alternative to fusion. Demand continues to expand as patients and physicians favor procedures that maintain natural motion, reduce adjacent segment disease, and lower the likelihood of revision surgeries.
Market Overview
Motion preservation devices, including artificial discs and dynamic stabilization systems, are designed to restore spinal function while preserving the spine’s normal biomechanics. These technologies serve as alternatives to fusion, which permanently restricts motion at the treated segment.
Growth is being driven by the combination of favorable clinical outcomes, rising patient awareness, and improved reimbursement structures. Artificial discs, used primarily in cervical and lumbar applications, mimic the natural movement of the disc while providing stability. Dynamic stabilization devices, applied in posterior approaches, limit excessive motion while maintaining controlled flexibility. Both device types are expanding adoption as more surgeons receive specialized training and as supporting long-term data becomes available.
Historically, fusion procedures dominated surgical treatment for spinal degeneration. However, evidence linking fusion to adjacent segment degeneration and limited range of motion has increased interest in motion-preserving techniques. Studies indicate that when patients are given a choice between a fusion and a motion-preserving procedure, they generally prefer motion preservation when cost is not a factor. This preference has accelerated procedural adoption, particularly in developed healthcare markets with established reimbursement pathways.
Regulatory and reimbursement landscapes are also improving. Several countries have revised coverage to include cervical and, in selected cases, lumbar artificial discs, acknowledging consistent clinical benefit and durability. As data from multi-center studies continues to demonstrate safety and efficacy, motion preservation is expected to capture a growing share of spine procedures traditionally treated with fusion.
Market Drivers
Alternative to Fusion
Artificial discs aim to maintain the spine’s natural range of motion, contrasting with spinal fusion, which restricts movement and may lead to additional stress on adjacent levels. Clinical studies show that patients treated with artificial discs experience faster recovery and reduced likelihood of secondary procedures. As awareness of these benefits increases, patients and physicians are shifting preference toward motion-preserving devices.
Additionally, evidence suggests that spinal fusion patients face higher rates of revision surgery due to adjacent segment degeneration. These outcomes reinforce clinical confidence in motion preservation, supporting growth in both cervical artificial discs (CADs) and lumbar artificial discs (LADs) over the forecast period.
Reimbursement Changes
Reimbursement has a strong influence on procedure volumes. For lumbar artificial discs, coverage expansion is expected as favorable results accumulate, with increasing acceptance among private insurers. Reimbursement rates have improved steadily over the past several years, allowing more patients to access motion-preserving technologies.
Cervical artificial discs have seen a particularly favorable shift. Positive clinical outcomes and long-term reliability have led to broader reimbursement acceptance, especially where CADs demonstrate equivalence or superiority to traditional cervical fusion. This trend continues to create a stable financial environment for hospitals and manufacturers operating in the segment.
Clinical Indications for CADs
Cervical artificial discs have fewer contraindications than their lumbar counterparts. Because the cervical spine bears less weight, it is less prone to instability issues that limit LAD adoption. Consequently, CADs can be implanted in a broader range of patients and at multiple levels, expanding the addressable market. Multi-level cervical procedures further increase unit sales potential. As physicians gain familiarity with implant techniques and clinical outcomes, CADs are expected to see consistent growth across all major regions.
Patient Preference and Education
Patient education initiatives emphasizing mobility preservation, quality of life, and lower revision rates have strengthened demand for motion preservation over fusion. As access to medical information grows and more patients request less invasive options, surgeon recommendations are increasingly aligned with patient expectations, reinforcing the adoption of these technologies.
Market Limiters
Clinical Contraindications for LADs
The most significant constraint on the lumbar artificial disc market is its limited clinical indication set. Contraindications include osteoporosis, spondylolisthesis, obesity, and instability of the vertebral column. LADs are currently indicated for single-level use only, reducing the eligible patient population.
Another limitation is procedural complexity. LAD implantation often requires a more invasive posterior approach, which is unfamiliar to some surgeons and presents additional challenges. Although newer LAD designs are being developed for anterior implantation to simplify access, widespread adoption will depend on further regulatory approvals and published outcomes.
Traditional Fusion Procedures
Conventional fixation and fusion continue to represent the standard of care for many indications. Fusion devices are less costly, have established reimbursement, and remain widely available. Surgeons comfortable with fusion techniques may be hesitant to switch to motion preservation until longer-term data supports clear superiority. Cost differences also influence hospital purchasing decisions, especially in regions where motion preservation devices are viewed as premium technologies.
Training and Infrastructure
Adoption of artificial discs and dynamic stabilization systems requires specialized training and equipment. Institutions without experienced teams or imaging capabilities may delay adoption. Additionally, some payers require documentation of surgeon training or device certification to qualify for reimbursement, limiting procedural accessibility in lower-volume centers.
Regulatory Variability
Regional variations in regulatory approval and reimbursement timelines can delay market penetration. Markets with more conservative evaluation frameworks or complex pre-market submission requirements tend to adopt new disc technologies more slowly, impacting overall global growth rates.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
Qualitative Coverage
Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, and disease overviews relevant to motion preservation.
Time Frame
Base year 2024, forecasts 2025 through 2032, historical data 2022 to 2024.
Data Sources
Primary interviews with spinal surgeons, device manufacturers, and healthcare administrators; regulatory filings; reimbursement databases; and iData Research’s internal MedTech dataset.
Method Note
Revenue models are based on units multiplied by ASP, cross-checked against procedure numbers and replacement cycles.
Care Settings
Hospitals, specialty spine centers, and select ambulatory surgery centers offering motion-preserving spinal procedures.
Markets Covered and Segmentation
Motion Preservation Device Market – Further Segmented Into:
Artificial Disc
Dynamic Stabilization
Each segment is analyzed by units, ASPs, and market values, with forecasts to 2032 and historical trends to 2022.
Competitive Analysis
ZimVie / Highridge Medical led the global motion preservation device market in 2024. The company maintained its leadership across most major regions, driven primarily by the success of its Mobi-C® Cervical Artificial Disc. The Mobi-C® system’s proven design, multi-level indication, and strong clinical evidence have supported broad adoption and reimbursement coverage. Following the company’s transition under Highridge Medical, product performance and brand recognition continue to strengthen its position globally.
Globus Medical / NuVasive was the second-largest competitor in 2024, supported by its SECURE®-C and SECURE®-C3 cervical disc systems, designed to replicate natural motion and enhance post-operative imaging quality. Globus also maintains share in the dynamic posterior stabilization and interspinous fixation segments. NuVasive contributes to this leadership through its Simplify® Cervical Disc, a motion-preserving, MRI-compatible solution that demonstrates strong clinical results. Following their merger, the combined company leverages a broad spine portfolio, integrating motion preservation with navigation and surgical planning systems.
Orthofix ranked third globally in 2024. Its M6-C™ Artificial Cervical Disc, acquired through the Spinal Kinetics merger, anchors its presence in cervical motion preservation. Orthofix also participates in dynamic stabilization technologies designed to maintain flexibility in non-fusion procedures. The company maintains a strong footprint in North America and Europe, supported by training partnerships and product innovation in motion restoration.
Collectively, these three manufacturers represent the majority of global motion preservation revenue. Competition is expected to intensify as additional disc technologies gain regulatory approval and as new entrants introduce next-generation dynamic systems with improved biomechanical performance.
Technology and Practice Trends
Cervical artificial discs continue to expand due to favorable indications, multi-level capabilities, and strong long-term outcomes.
Lumbar artificial discs face slower growth but benefit from active research into improved materials and anterior surgical approaches.
Dynamic stabilization systems offer hybrid solutions that maintain partial motion and can be used adjunctively with fusion in selective cases.
Material innovation includes titanium endplates, viscoelastic cores, and advanced polymer composites designed to mimic natural disc properties.
MRI compatibility and imaging clarity improvements support better post-operative monitoring.
Minimally invasive techniques for disc implantation are gaining popularity, reducing recovery times and hospital stays.
Integration with navigation and robotic guidance enhances accuracy and reproducibility during device placement.
Post-market studies continue to evaluate device durability and long-term biomechanics, helping strengthen regulatory and payer confidence.
Geography
This edition provides global coverage for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Why This Report
Where are the largest and fastest-growing opportunities within the motion preservation market by device type and region
How will patient preference for mobility and reimbursement changes influence market expansion
What are the clinical and procedural barriers affecting LAD versus CAD adoption
How do training, infrastructure, and regulatory factors shape adoption curves across geographies
What are the key technology trends, including dynamic stabilization and anterior approach LADs
How are leading players—ZimVie, Globus Medical/NuVasive, and Orthofix—positioning their portfolios and partnerships for continued growth
The Global Motion Preservation Device Market Report from iData Research answers these questions with procedure-based models, company share data, and price analysis. Use it to quantify opportunity, align strategic planning, and guide investment or product development decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
95 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
